Delayed start analysis of ADAS-Cog14 scores in patients mild AD from the EXPEDITION, EXPEDITION2, and EXPEDITION-EXT studies of solanezumab.Hong LiuSeifertScott W. AndersenIlya LipkovichKaren C. HoldridgeEric Siemers
此外,低 tau 蛋白负荷患者的疗效指标结果不一致:接受 lecanemab 治疗的患者 CDR-SB 相比基线确实改善了,但 ADAS-Cog14(认知)和 ADCS MCI-ADL(功能)两项指标 lecanemab 治疗患者相比基线却都恶化了。这种背道而驰的结果无疑会影响疗效结论的可靠性。
Sensitivity of memory subtests and learning slopes from the ADAS-Cog to distinguish along the continuum of the NIA-AA Research Framework for Alzheimer鈥檚 DiseaseABSTRACTDustin B HammersRalitsa V KostadinovaRobert J SpencerJean N IkangaFrederick W Unverzagt...